Robert Zaczek new CSO at NeurOp
This article was originally published in Scrip
Executive Summary
Atlanta-based biopharmaceutical company NeurOp, which specialises in developing new medicines for central nervous system disorders, has appointed Dr Robert Zaczek chief scientific officer. Dr Zaczek most recently served as executive director of psychiatry drug discovery at Bristol-Myers Squibb, during which time he headed the joint research team that currently collaborates with NeurOp on its depression and neuropathic pain programmes.